Laura Flavell, PhD,  —

Recent Posts

• Exercise-induced Irisin Hormone May Be Muscle Loss Biomarker June 24, 2022
• MicroRNA-based Gene Therapy for CMT1A Shows Promise in Mice June 22, 2022
• Foot Deformity Doesn’t Affect Walking Impairments in CMT: Study June 17, 2022
• NORD’s ‘Living Rare, Living Stronger’ Patient, Family Forum Set for June 26 June 10, 2022
• CMT2S Patient Features, New Gene Mutations ID’d in Chinese Study June 8, 2022
• Patient Enrollment Complete for PREMIER Trial of PXT3003 June 3, 2022
• IFB-088 Aids Myelin Formation in CMT1 Mouse Models May 27, 2022
• Rare POLR3B Mutation Again Linked to Early-onset CMT Type 1 May 25, 2022
• Finding Joy and Self-love Through Movement May 24, 2022
• PXT3003 Continues to Safely Treat CMT1A Patients Over Long Term May 18, 2022